Illinois Prostate Cancer Screening & Awareness
The Illinois Prostate Screening and Awareness (IL-PSA) program is a statewide initiative to effectively deliver culturally and linguistically appropriate prostate cancer education through local health departments, federally qualified health clinics, and community-based organizations that serve age-appropriate men within African American and Hispanic/Latino communities.
Selected community partners will provide prostate cancer education, awareness, and linkage-to-care opportunities through targeted education and awareness campaigns that engage with the communities in their catchment area.
Illinois Prostate Cancer Screening & Awareness
According to the National Cancer Institute, 1 in every 8 men in the United States will develop prostate cancer in their lifetime, and in 2021, 34,130 were estimated to die from this disease (1,210 deaths in Illinois). Racial and ethnic disparities in prostate cancer survival are well documented. In the US, African American men are 70% more likely to be diagnosed with prostate cancer and are more than twice as likely to die of the disease compared to Non-Hispanic, White men (American Cancer Society). Moreover, although Hispanic/Latino men are less likely to get screened for prostate cancer compared to White men, cancer of the prostate is the most commonly diagnosed cancer in Hispanic/Latinos (21% as reported in the American Cancer Society).
The Illinois Prostate Screening and Awareness (IL-PSA) program is a statewide initiative to effectively deliver culturally and linguistically appropriate prostate cancer education through local health departments, federally qualified health clinics, and community-based organizations that serve age-appropriate men within African American and Hispanic/Latino communities. Selected community partners will provide prostate cancer education, awareness, and linkage-to-care opportunities through targeted education and awareness campaigns that engage with the communities in their catchment area.
Source - U.S. Cancer Statistics Working Group. U.S. Cancer Statistics Data Visualizations Tool, based on 2020 submission data (1999-2018): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; https://www.cdc.gov/cancer/dataviz, released in June 2021.